¾ÅÉ«ÊÓƵ

Personalised medicine is the next great global challenge for the pharmaceutical industry. The vision of the pharmacy of the future is one which employs disruptive technologies to enable on-demand manufacture of drugs designed to individual needs. Central to this vision is the concept of continuous processing. The Bernal Chair in Pharmaceutical Powder Engineering, Prof Gavin Walker, discusses how continuous processing is a key enabler to impact on global health through delivering more tailored and targeted medicines.

Anne MacFarlane, Professor of Primary Healthcare Research at the Graduate Entry Medical School, ¾ÅÉ«ÊÓƵ and member of UL’s Health Research Institute talks about her research in the area of Public and Patient Involvement in Research, specifically participatory health research with socially excluded communities.

Recorded by GK Media Ltd.

Tax fraud and tax evasion affects us all. Within the European Union, huge sums of revenue for public investment are being lost due to tax evasion and avoidance with estimates in the region of 1 trillion euros. Prof Sheila Killian of the Kemmy Business School talks about her research as part of the EU funded project called COFFERS - Combatting Fiscal Fraud and Empowering Regulators. The team at the Kemmy Business School are focusing on the role of expert professional networks, tax advisers, wealth managers and the factors which can lead them to take ethical or aggressive approaches to their tax work.

Recorded by GK Media Ltd.

Lecture as part of Inaugural UL’s Research Week by Prof Karel Luyben, former Rector Magnificus of TU Delft and an expert on Open Science. During his lecture Prof Luyben poses questions such as; What concrete conditions should be met first, for your organisation to embrace Open Science? What do you hope that your organisation will gain from open science? What is the number one prerequisite for you personally with respect to Open Science implementation? What role are you willing to take for the implementation of open science? Either from your personal point of view, or your professional position. What is in your opinion be the main risk of Open Science for your organisation? What should be done to prevent it? What is the main contribution of your organisation to the implementation of Open Science?

The advent of the electric car heralds a new era of environmentally friendly transport. However, battery cost could put a brake on the rollout of electric vehicles (EVs) for a mass market. Prof Kevin M Ryan, Chair in Chemical Nanotechnology, at the Bernal Institute, ¾ÅÉ«ÊÓƵ and his team are co-ordinating European research projects, Si-Drive and NEILLSBAT looking at next generation battery technology for EVs. This team are tackling the major barriers to EV uptake, which relate to driving range, cost and recharge times by completely re-imagining the lithium ion battery with new and innovative materials.

Recorded by GK Media Ltd.

Dr Jakki Cooney, co-founder of UL spinout Cala Medical, based in the Nexus Innovation Centre in UL discusses her research. Cala Medical have designed and patented a unique device containing a specific immobilized enzyme which treats the excessive inflammatory response in the blood of sepsis patients. The treatment could dramatically cut the death rate from sepsis which is a highly prevalent and often fatal illness requiring intensive medical care. Jakki also discusses her experiences as a female researcher working in STEM and the challenges and rewards that this can bring.
Recorded by GK Media Ltd.